98%
921
2 minutes
20
Background: Although multifaceted control intervention actions (bundles) are highly effective in reducing the risk of device-related healthcare-associated infections (d-HAIs), no studies have explored their impact on the outcomes of kidney transplant recipients (KTRs) or the extent of risk reduction achievable through the bundle implementation.
Methods: Seven hundred ninety-eight prevalent KTRs admitted to the intensive care unit (ICU) requiring invasive devices were included: 449 patients from the bundle preimplementation period and 349 from the postimplementation period. The primary outcome was mortality within 90 d of ICU admission. Using Poisson regression models, the magnitude of risk reduction for d-HAIs after the bundle implementation and the impact of d-HAIs on the risk of death was estimated.
Results: The 90-d survival rate was significantly lower in patients with d-HAIs (37.7% versus 71.7%; < 0.001). The bundle implementation reduced the risk of d-HAIs by 58% (relative risk, 0.42; = 0.005). Despite the significant reduction in d-HAIs after the bundle implementation, d-HAIs were associated with a 2.6-fold higher risk of death (hazard ratio [HR], 2.63; < 0.001) regardless of the study period. Additional variables associated with increased risk of death included age (HR, 1.03; < 0.001), baseline immunosuppression (HR based on mycophenolate versus others 0.74; = 0.02), time since transplantation (HR, 1.003; < 0.001), platelet count at ICU admission (HR, 0.998; < 0.001), and sepsis as the reason for ICU admission (HR, 1.67; < 0.001).
Conclusions: The persistent risk associated with d-HAIs, despite the implementation of multifaceted control intervention actions in an ICU specialized in KTR care, underscores the need for a zero-tolerance policy toward d-HAIs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11723676 | PMC |
http://dx.doi.org/10.1097/TXD.0000000000001754 | DOI Listing |
Adv Mater
September 2025
Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117585, Singapore.
Bioelectronic devices hold significant promise for advancing biomedical technologies, addressing critical healthcare challenges, and improving the quality of human life. Conventional bioelectronic devices are typically powered by external, bulky batteries connected by extended electrical wires, which limit the compactness and miniaturization of bioelectronics, restrict patient mobility, and increase the risk of complications such as infections and device-related failures. This perspective discusses the emerging concept of galvanic-cell-based self-powered bioelectronic devices, in which galvanic electrodes serve directly as the tissue-contacting interfaces.
View Article and Find Full Text PDFDiabetol Metab Syndr
August 2025
Department of Internal Medicine, Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
Background: Monitoring glucose levels is crucial for managing glycemic control. Methods include self-monitored blood glucose (SMBG), continuous glucose monitoring (CGM), and intermittently scanned continuous glucose monitoring (isCGM).
Objective: To assess the efficacy of isCGM versus SMBG in individuals with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) on insulin therapy.
JACC Case Rep
August 2025
Department of Cardiology, Southeast Health, Dothan, Alabama, USA.
Background: Left atrial appendage closure with the Watchman FLX Pro device (Boston Scientific) is an alternative to anticoagulation in patients at high bleeding risk with atrial fibrillation. Intraprocedural thrombus formation is rare and poses a unique challenge.
Case Summary: A 57-year-old man with paroxysmal atrial fibrillation and prior intracranial hemorrhage underwent elective left atrial appendage closure.
J Clin Med
August 2025
Department of Vascular Surgery, University Clinical Centre in Gdańsk, 80-952 Gdańsk, Poland.
To analyze the effect of abdominal aortic aneurysm (AAA) diameter on late complication occurrence and survival in patients following endovascular aneurysm repair (EVAR). The study was a retrospective cohort analysis with a prospective follow-up of 176 patients diagnosed with unruptured AAA who underwent EVAR from 2016 to 2024. Preoperative computed tomography (CT) images were used to measure maximal aneurysm diameter.
View Article and Find Full Text PDFBiomedicines
August 2025
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
: Patients with end-stage renal disease (ESRD) are at elevated risk for device-related complications following pacemaker implantation. Leadless pacemakers (LPMs) offer theoretical advantages over transvenous pacemakers (TVPs), but their safety and efficacy in this high-risk population remain unclear. Our aim was to compare clinical outcomes and complication profiles between leadless and transvenous pacemakers in patients with ESRD.
View Article and Find Full Text PDF